UniProt ID | HDAC4_HUMAN | |
---|---|---|
UniProt AC | P56524 | |
Protein Name | Histone deacetylase 4 | |
Gene Name | HDAC4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1084 | |
Subcellular Localization | Nucleus. Cytoplasm. Shuttles between the nucleus and the cytoplasm. Upon muscle cells differentiation, it accumulates in the nuclei of myotubes, suggesting a positive role of nuclear HDAC4 in muscle differentiation. The export to cytoplasm depends on | |
Protein Description | Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Involved in muscle maturation via its interaction with the myocyte enhancer factors such as MEF2A, MEF2C and MEF2D. Involved in the MTA1-mediated epigenetic regulation of ESR1 expression in breast cancer. Deacetylates HSPA1A and HSPA1B at 'Lys-77' leading to their preferential binding to co-chaperone STUB1. [PubMed: 27708256] | |
Protein Sequence | MSSQSHPDGLSGRDQPVELLNPARVNHMPSTVDVATALPLQVAPSAVPMDLRLDHQFSLPVAEPALREQQLQQELLALKQKQQIQRQILIAEFQRQHEQLSRQHEAQLHEHIKQQQEMLAMKHQQELLEHQRKLERHRQEQELEKQHREQKLQQLKNKEKGKESAVASTEVKMKLQEFVLNKKKALAHRNLNHCISSDPRYWYGKTQHSSLDQSSPPQSGVSTSYNHPVLGMYDAKDDFPLRKTASEPNLKLRSRLKQKVAERRSSPLLRRKDGPVVTALKKRPLDVTDSACSSAPGSGPSSPNNSSGSVSAENGIAPAVPSIPAETSLAHRLVAREGSAAPLPLYTSPSLPNITLGLPATGPSAGTAGQQDAERLTLPALQQRLSLFPGTHLTPYLSTSPLERDGGAAHSPLLQHMVLLEQPPAQAPLVTGLGALPLHAQSLVGADRVSPSIHKLRQHRPLGRTQSAPLPQNAQALQHLVIQQQHQQFLEKHKQQFQQQQLQMNKIIPKPSEPARQPESHPEETEEELREHQALLDEPYLDRLPGQKEAHAQAGVQVKQEPIESDEEEAEPPREVEPGQRQPSEQELLFRQQALLLEQQRIHQLRNYQASMEAAGIPVSFGGHRPLSRAQSSPASATFPVSVQEPPTKPRFTTGLVYDTLMLKHQCTCGSSSSHPEHAGRIQSIWSRLQETGLRGKCECIRGRKATLEELQTVHSEAHTLLYGTNPLNRQKLDSKKLLGSLASVFVRLPCGGVGVDSDTIWNEVHSAGAARLAVGCVVELVFKVATGELKNGFAVVRPPGHHAEESTPMGFCYFNSVAVAAKLLQQRLSVSKILIVDWDVHHGNGTQQAFYSDPSVLYMSLHRYDDGNFFPGSGAPDEVGTGPGVGFNVNMAFTGGLDPPMGDAEYLAAFRTVVMPIASEFAPDVVLVSSGFDAVEGHPTPLGGYNLSARCFGYLTKQLMGLAGGRIVLALEGGHDLTAICDASEACVSALLGNELDPLPEKVLQQRPNANAVRSMEKVMEIHSKYWRCLQRTTSTAGRSLIEAQTCENEEAETVTAMASLSVGVKPAEKRPDEEPMEEEPPL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSSQSHPDG ------CCCCCCCCC | 48.68 | 25599653 | |
3 | Phosphorylation | -----MSSQSHPDGL -----CCCCCCCCCC | 47.78 | 27251275 | |
5 | Phosphorylation | ---MSSQSHPDGLSG ---CCCCCCCCCCCC | 38.65 | 27251275 | |
11 | Phosphorylation | QSHPDGLSGRDQPVE CCCCCCCCCCCCCCH | 36.99 | 20068231 | |
36 | Phosphorylation | PSTVDVATALPLQVA CCCCCHHHHCCCEEC | 28.68 | 27251275 | |
45 | Phosphorylation | LPLQVAPSAVPMDLR CCCEECCCCCCCCEE | 31.96 | 27251275 | |
58 | Phosphorylation | LRLDHQFSLPVAEPA EECCCCCCCCCCCHH | 25.78 | 28857561 | |
79 | Ubiquitination | QQELLALKQKQQIQR HHHHHHHHHHHHHHH | 50.25 | 29967540 | |
151 | Ubiquitination | EKQHREQKLQQLKNK HHHHHHHHHHHHHHH | 43.44 | 29967540 | |
168 | Phosphorylation | GKESAVASTEVKMKL CCHHHCCHHHHHHHH | 20.64 | - | |
196 | Phosphorylation | RNLNHCISSDPRYWY CCCCHHHCCCCCCCC | 33.80 | 28450419 | |
197 | Phosphorylation | NLNHCISSDPRYWYG CCCHHHCCCCCCCCC | 31.55 | 28450419 | |
206 | Phosphorylation | PRYWYGKTQHSSLDQ CCCCCCCCCCCCCCC | 27.44 | 23401153 | |
209 | Phosphorylation | WYGKTQHSSLDQSSP CCCCCCCCCCCCCCC | 23.84 | 28450419 | |
210 | Phosphorylation | YGKTQHSSLDQSSPP CCCCCCCCCCCCCCC | 33.56 | 25159151 | |
214 | Phosphorylation | QHSSLDQSSPPQSGV CCCCCCCCCCCCCCC | 44.47 | 28450419 | |
215 | Phosphorylation | HSSLDQSSPPQSGVS CCCCCCCCCCCCCCC | 34.66 | 26657352 | |
219 | Phosphorylation | DQSSPPQSGVSTSYN CCCCCCCCCCCCCCC | 47.11 | 28450419 | |
222 | Phosphorylation | SPPQSGVSTSYNHPV CCCCCCCCCCCCCCC | 18.37 | 30576142 | |
223 | Phosphorylation | PPQSGVSTSYNHPVL CCCCCCCCCCCCCCC | 32.59 | 30576142 | |
224 | Phosphorylation | PQSGVSTSYNHPVLG CCCCCCCCCCCCCCC | 19.21 | 28450419 | |
225 | Phosphorylation | QSGVSTSYNHPVLGM CCCCCCCCCCCCCCC | 19.99 | 28450419 | |
233 | Phosphorylation | NHPVLGMYDAKDDFP CCCCCCCEECCCCCC | 15.79 | 26074081 | |
236 | Acetylation | VLGMYDAKDDFPLRK CCCCEECCCCCCCCC | 55.74 | 20167786 | |
243 | Ubiquitination | KDDFPLRKTASEPNL CCCCCCCCCCCCCCH | 57.01 | - | |
244 | Phosphorylation | DDFPLRKTASEPNLK CCCCCCCCCCCCCHH | 29.05 | 30183078 | |
246 | Phosphorylation | FPLRKTASEPNLKLR CCCCCCCCCCCHHHH | 59.84 | 25159151 | |
251 | Acetylation | TASEPNLKLRSRLKQ CCCCCCHHHHHHHHH | 48.79 | 25953088 | |
265 | Phosphorylation | QKVAERRSSPLLRRK HHHHHHHCCCCHHCC | 42.39 | 25159151 | |
266 | Phosphorylation | KVAERRSSPLLRRKD HHHHHHCCCCHHCCC | 20.11 | 26846344 | |
278 | Phosphorylation | RKDGPVVTALKKRPL CCCCCCEEEEECCCC | 26.89 | 18491316 | |
281 | Acetylation | GPVVTALKKRPLDVT CCCEEEEECCCCCCC | 44.25 | 25953088 | |
288 | Phosphorylation | KKRPLDVTDSACSSA ECCCCCCCCCCCCCC | 24.73 | 20873877 | |
290 | Phosphorylation | RPLDVTDSACSSAPG CCCCCCCCCCCCCCC | 23.08 | 20873877 | |
293 | Phosphorylation | DVTDSACSSAPGSGP CCCCCCCCCCCCCCC | 29.29 | 20873877 | |
294 | Phosphorylation | VTDSACSSAPGSGPS CCCCCCCCCCCCCCC | 38.06 | 20873877 | |
298 | Phosphorylation | ACSSAPGSGPSSPNN CCCCCCCCCCCCCCC | 46.61 | 20873877 | |
301 | Phosphorylation | SAPGSGPSSPNNSSG CCCCCCCCCCCCCCC | 63.05 | 30576142 | |
302 | Phosphorylation | APGSGPSSPNNSSGS CCCCCCCCCCCCCCC | 34.48 | 30576142 | |
306 | Phosphorylation | GPSSPNNSSGSVSAE CCCCCCCCCCCCCCC | 42.59 | 20873877 | |
307 | Phosphorylation | PSSPNNSSGSVSAEN CCCCCCCCCCCCCCC | 36.89 | 20873877 | |
309 | Phosphorylation | SPNNSSGSVSAENGI CCCCCCCCCCCCCCC | 18.17 | 20873877 | |
311 | Phosphorylation | NNSSGSVSAENGIAP CCCCCCCCCCCCCCC | 31.40 | 20873877 | |
321 | Ubiquitination | NGIAPAVPSIPAETS CCCCCCCCCCCCCCC | 28.75 | - | |
322 | Phosphorylation | GIAPAVPSIPAETSL CCCCCCCCCCCCCCH | 34.31 | 20873877 | |
327 | Phosphorylation | VPSIPAETSLAHRLV CCCCCCCCCHHHHHH | 31.02 | 20873877 | |
328 | Phosphorylation | PSIPAETSLAHRLVA CCCCCCCCHHHHHHH | 18.31 | 20873877 | |
339 | Phosphorylation | RLVAREGSAAPLPLY HHHHCCCCCCCCCCC | 19.26 | 28464451 | |
346 | Phosphorylation | SAAPLPLYTSPSLPN CCCCCCCCCCCCCCC | 11.84 | 27080861 | |
347 | Phosphorylation | AAPLPLYTSPSLPNI CCCCCCCCCCCCCCE | 41.67 | 27080861 | |
348 | Phosphorylation | APLPLYTSPSLPNIT CCCCCCCCCCCCCEE | 10.03 | 29802988 | |
350 | Phosphorylation | LPLYTSPSLPNITLG CCCCCCCCCCCEEEE | 57.11 | 28857561 | |
355 | Phosphorylation | SPSLPNITLGLPATG CCCCCCEEEECCCCC | 22.78 | 27080861 | |
361 | Phosphorylation | ITLGLPATGPSAGTA EEEECCCCCCCCCCC | 47.92 | 27080861 | |
364 | Phosphorylation | GLPATGPSAGTAGQQ ECCCCCCCCCCCCHH | 40.45 | 27080861 | |
367 | Phosphorylation | ATGPSAGTAGQQDAE CCCCCCCCCCHHHHH | 27.60 | 27080861 | |
391 | Phosphorylation | RLSLFPGTHLTPYLS HHCCCCCCCCCCCCC | 17.60 | 21712546 | |
394 | Phosphorylation | LFPGTHLTPYLSTSP CCCCCCCCCCCCCCC | 11.41 | 21712546 | |
396 | Phosphorylation | PGTHLTPYLSTSPLE CCCCCCCCCCCCCCC | 14.19 | 28450419 | |
398 | Phosphorylation | THLTPYLSTSPLERD CCCCCCCCCCCCCCC | 22.46 | 28450419 | |
399 | Phosphorylation | HLTPYLSTSPLERDG CCCCCCCCCCCCCCC | 31.59 | 28450419 | |
400 | Phosphorylation | LTPYLSTSPLERDGG CCCCCCCCCCCCCCC | 24.90 | 28450419 | |
465 | Phosphorylation | QHRPLGRTQSAPLPQ HCCCCCCCCCCCCCC | 25.69 | 23927012 | |
467 | Phosphorylation | RPLGRTQSAPLPQNA CCCCCCCCCCCCCHH | 31.10 | 23927012 | |
472 | Phosphorylation | TQSAPLPQNAQALQH CCCCCCCCHHHHHHH | 66.62 | 32142685 | |
494 | Ubiquitination | QQFLEKHKQQFQQQQ HHHHHHHHHHHHHHH | 57.79 | 29967540 | |
540 | Phosphorylation | QALLDEPYLDRLPGQ HHHHCCHHHHCCCCC | 21.13 | 27642862 | |
548 | Acetylation | LDRLPGQKEAHAQAG HHCCCCCHHHHHHHC | 63.88 | 7834049 | |
559 | Sumoylation | AQAGVQVKQEPIESD HHHCCCCCCCCCCCC | 31.67 | 12032081 | |
559 | Sumoylation | AQAGVQVKQEPIESD HHHCCCCCCCCCCCC | 31.67 | - | |
565 | Phosphorylation | VKQEPIESDEEEAEP CCCCCCCCCCCCCCC | 51.55 | 29255136 | |
570 | Phosphorylation | IESDEEEAEPPREVE CCCCCCCCCCCCCCC | 37.56 | 33259812 | |
584 | Phosphorylation | EPGQRQPSEQELLFR CCCCCCCCHHHHHHH | 43.50 | 26074081 | |
610 | Ubiquitination | HQLRNYQASMEAAGI HHHHHHHHHHHHHCC | 10.65 | - | |
611 | Phosphorylation | QLRNYQASMEAAGIP HHHHHHHHHHHHCCC | 11.13 | 26437602 | |
620 | Phosphorylation | EAAGIPVSFGGHRPL HHHCCCCCCCCCCCC | 16.90 | 28348404 | |
628 | Phosphorylation | FGGHRPLSRAQSSPA CCCCCCCCCCCCCCC | 28.40 | 28348404 | |
632 | Phosphorylation | RPLSRAQSSPASATF CCCCCCCCCCCCCCC | 36.99 | 29255136 | |
633 | Phosphorylation | PLSRAQSSPASATFP CCCCCCCCCCCCCCC | 16.65 | 29255136 | |
636 | Phosphorylation | RAQSSPASATFPVSV CCCCCCCCCCCCCCC | 31.09 | 23927012 | |
637 | Phosphorylation | AQSSPASATFPVSVQ CCCCCCCCCCCCCCC | 18.50 | 32645325 | |
638 | Phosphorylation | QSSPASATFPVSVQE CCCCCCCCCCCCCCC | 26.44 | 23927012 | |
642 | Phosphorylation | ASATFPVSVQEPPTK CCCCCCCCCCCCCCC | 20.51 | 23927012 | |
642 | O-linked_Glycosylation | ASATFPVSVQEPPTK CCCCCCCCCCCCCCC | 20.51 | 31195810 | |
643 | Phosphorylation | SATFPVSVQEPPTKP CCCCCCCCCCCCCCC | 8.33 | 32142685 | |
648 | Phosphorylation | VSVQEPPTKPRFTTG CCCCCCCCCCCCCCC | 65.48 | 23927012 | |
658 | Phosphorylation | RFTTGLVYDTLMLKH CCCCCHHHHHHHHEE | 14.30 | 29116813 | |
684 | Phosphorylation | EHAGRIQSIWSRLQE HHHHHHHHHHHHHHH | 24.53 | 28857561 | |
705 | Ubiquitination | CECIRGRKATLEELQ CEECCCCCCCHHHHH | 48.85 | 29967540 | |
737 | Ubiquitination | RQKLDSKKLLGSLAS HHHCCHHHHHHHHHH | 53.55 | - | |
741 | Phosphorylation | DSKKLLGSLASVFVR CHHHHHHHHHHHHHC | 22.26 | - | |
744 | Phosphorylation | KLLGSLASVFVRLPC HHHHHHHHHHHCCCC | 22.75 | - | |
830 | Phosphorylation | KLLQQRLSVSKILIV HHHHHHHCCCEEEEE | 26.91 | 24719451 | |
1025 | Phosphorylation | EKVMEIHSKYWRCLQ HHHHHHHHHHHHHHH | 32.85 | - | |
1026 | Ubiquitination | KVMEIHSKYWRCLQR HHHHHHHHHHHHHHH | 34.37 | 29967540 | |
1034 | Phosphorylation | YWRCLQRTTSTAGRS HHHHHHHHCCHHCCC | 16.49 | 20068231 | |
1036 | Phosphorylation | RCLQRTTSTAGRSLI HHHHHHCCHHCCCHH | 18.69 | 26546556 | |
1057 | Phosphorylation | NEEAETVTAMASLSV CCCHHHHHHHHHHCC | 20.38 | - | |
1061 | Phosphorylation | ETVTAMASLSVGVKP HHHHHHHHHCCCCCC | 14.21 | - | |
1078 | Sulfoxidation | KRPDEEPMEEEPPL- HCCCCCCCCCCCCC- | 13.16 | 21406390 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
210 | S | Phosphorylation | Kinase | CAMK2D | Q13557 | PSP |
246 | S | Phosphorylation | Kinase | SIK1 | P57059 | Uniprot |
246 | S | Phosphorylation | Kinase | MARK2 | Q7KZI7 | PSP |
246 | S | Phosphorylation | Kinase | CAMK4 | Q16566 | Uniprot |
246 | S | Phosphorylation | Kinase | MAP3K7 | O43318 | GPS |
265 | S | Phosphorylation | Kinase | PKACA | P17612 | PSP |
265 | S | Phosphorylation | Kinase | PKACA | P05132 | PSP |
266 | S | Phosphorylation | Kinase | PKACA | P17612 | PSP |
266 | S | Phosphorylation | Kinase | PKACA | P05132 | PSP |
298 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
302 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
467 | S | Phosphorylation | Kinase | KKCC1 | Q8N5S9 | PhosphoELM |
467 | S | Phosphorylation | Kinase | CAMK4 | Q16566 | Uniprot |
467 | S | Phosphorylation | Kinase | SIK1 | P57059 | Uniprot |
584 | S | Phosphorylation | Kinase | PKACA | P17612 | PSP |
632 | S | Phosphorylation | Kinase | CAMK4 | Q16566 | Uniprot |
632 | S | Phosphorylation | Kinase | KKCC1 | Q8N5S9 | PhosphoELM |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HDAC4_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
600430 | Brachydactyly-mental retardation syndrome (BDMR) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-350, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-565; SER-632 ANDSER-633, AND MASS SPECTROMETRY. | |
"Regulation of histone deacetylase 4 by binding of 14-3-3 proteins."; Wang A.H., Kruhlak M.J., Wu J., Bertos N.R., Vezmar M., Posner B.I.,Bazett-Jones D.P., Yang X.-J.; Mol. Cell. Biol. 20:6904-6912(2000). Cited for: PHOSPHORYLATION AT SER-246; SER-467 AND SER-632, AND MUTAGENESIS OFSER-246; SER-467 AND SER-632. | |
Sumoylation | |
Reference | PubMed |
"The SUMO E3 ligase RanBP2 promotes modification of the HDAC4deacetylase."; Kirsh O., Seeler J.-S., Pichler A., Gast A., Mueller S., Miska E.,Mathieu M., Harel-Bellan A., Kouzarides T., Melchior F., Dejean A.; EMBO J. 21:2682-2691(2002). Cited for: HOMODIMERIZATION, SUMOYLATION AT LYS-559, AND MUTAGENESIS OF LYS-559. |